Medicine

Huanhuan Li, Linhua Xuan, Yuehang Fan, Hua Li, Xinglin Jin, Ping Jiang, Ning Chen

2026.2.1Translational Cancer Research

DOI: 10.21037/tcr-2025-aw-2426

tlooto Summary

Meta-analysis indicated that the AM’s main active components exerted a beneficial effect on various indicators in HCC animals, including alanine aminotransferase (ALT) and high-dose AM, which reduced tumor volume and inhibition of tumor weight, tumor volume, and regulation of inflammatory response.

Abstract

Background Hepatic carcinoma (HCC) is a malignant tumor. This systematic review and meta-analysis aimed to explore the efficacy and possible mechanism of the main active ingredients of Astragalus membranaceus (AM) in HCC. Methods The study retrieved eight databases [PubMed, Web of Science, Embase, China Biomedical Literature Database (CBM), Cochrane Library, Wanfang Database (Wanfang), China Science and Technology Journal Database (VIP), and China National Knowledge Infrastructure (CNKI)]. The evaluation of methodological quality was conducted utilizing the risk of bias tool (SYRCLE). The study chose RevMan 5.4 for statistical analysis. Results Fifty-three studies involving 1,110 animals were selected. The risk of bias in studies was rated as low, medium, or high. Low-dose AM [n=140; standardized mean difference (SMD), −5.03; 95% confidence interval (CI): −6.95 to −3.10, low certainty] and high-dose AM (n=149; SMD, −5.80; 95% CI: −8.26 to −3.34, low certainty) reduced tumor volume. Meta-analysis indicated that the AM’s main active components exerted a beneficial effect on various indicators in HCC animals, including alanine aminotransferase (ALT) (n=156; SMD, −3.95; 95% CI: −6.13 to −1.78, low certainty), aspartate aminotransferase (AST) (n=126; SMD, −5.91; 95% CI: −9.00 to −2.82, low certainty), alkaline phosphatase (ALP) (n=80; SMD, −0.69; 95% CI: −1.80 to −0.42, low certainty), interleukin 2 (IL-2) (n=136; SMD, 2.88; 95% CI: 1.38 to 4.37, low certainty), interleukin 6 (IL-6) (n=95; SMD, 0.93; 95% CI: −2.05 to 3.91, low certainty), interferon-gamma (IFN-γ) (n=99; SMD, 4.67; 95% CI: 1.63 to 7.70, low certainty), and tumor necrosis factor-α (TNF-α) (n=236; SMD, 2.00; 95% CI: 0.66 to 3.33, low certainty). Conclusions The meta-analysis certifies the effectiveness of the AM’s main active ingredients in HCC based on early-phase investigations. The possible mechanism may link to inhibition of tumor weight, tumor volume, and regulation of inflammatory response.

Citation format

LI, Huanhuan, et al. Efficacy and potential mechanism of main active ingredients of astragalus membranaceus in animals with hepatocellular carcinoma: A systematic review and meta-analysis. Translational Cancer Research, 2026, 15(2): 114.